Hostname: page-component-6b989bf9dc-6f5p8 Total loading time: 0.001 Render date: 2024-04-14T08:52:52.276Z Has data issue: false hasContentIssue false
  • English
  • Français

The classification of psychotropic drugs

Published online by Cambridge University Press:  09 July 2009

Michael Shepherd  and
Helen Marshall
Michael Shepherd
Affiliation:
From the Institute of Psychiatry, University of London
Helen Marshall
Affiliation:
From the Institute of Psychiatry, University of London
Get access Rights & Permissions [Opens in a new window]

Synopsis

A survey is provided of the various attempts which have been advanced to classify psychotropic drugs. The unsatisfactory nature of the schemata and the underlying reasons for this are discussed. The possible use of ‘facet analysis’ to develop a classificatory system is suggested.

Type
Research Article
Information
Psychological Medicine , Volume 2 , Issue 2 , May 1972 , pp. 96 - 110
Copyright
Copyright © Cambridge University Press 1972

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Medical Association (1960). New and Nunofficial Drugs. Lippincott: Philadelphia.Google Scholar
Barkla, J. K. (1969). The University of Sheffield biomedical information project. The Information Scientist, 3, 13–30.Google Scholar
Bernard, C. (1957). An introduction to the Study of Experimental Medicine. Translated by Greene, H. C.. Dover: New York.Google Scholar
British National Formulary (1968), p. 68. B.M.A. and the Pharmaceutical Society of Great Britain: London.Google Scholar
Brodie, B. B., and Shore, P. A. (1959). Mechanism of action of psychotropic drugs. In Psychopharmacology Frontiers, pp. 413–419. Edited by Kline, N. S.. Little, Brown: Boston.Google Scholar
Clyde, D. J. (1968). Patterns of reaction to drug treatments derived through multivariate procedures. In The Role and Methodology of Classification in Psychiatry and Psycho-pathology, pp. 483–492. Edited by Katz, M. M., Cole, J. O., and Barton, W. E.. U.S. Department of Health, Education and Welfare: Washington.Google Scholar
Cook, L. (1965). Behavior changes with antipsychotic drugs in animals. In Neuropsychopharmacology. Vol. 4, pp. 91–99. Edited by Bente, D. and Bradley, P. B.. Elsevier: Amsterdam.Google Scholar
Cullen, W. (1798). A Treatise of the Materia Medica. Vol. 1. Elliott: Edinburgh.Google Scholar
Delay, J. (1959). In Psychopharmacology Frontiers, p. 426. Edited by Kline, N. S.. Little, Brown: Boston.Google Scholar
Deniker, P. (1966). La Psychopharmacologie. Presses Universitaires de France: Paris.Google Scholar
Department of Health and Social Security (1969). Annual Report for the Year 1968. H.M.S.O.: London.Google Scholar
Elkes, J. (1967). Behavioral pharmacology in relation to psychiatry. In Psychiatrie der Gegenwart, pp. 929–1038. Band 1/1, Teil A. Edited by Gruhle, H. W., Jung, R., Mayer-Gross, W., and Müller, M.. Springer: Berlin.Google Scholar
Fink, M. (1968). E.E.G. classification of psychoactive compounds in man: a review and theory of behavioural associations. In Psychopharmacology: a Review of Progress, 1957–1967. Edited by Efron, D. H., Cole, J. O., Levine, J., and Wittenborn, J. R.. Public Health Service Publication No. 1836: Washington D.C.Google Scholar
Freyhan, F. A. (1965). Dynamics and significance of psycho-pharmacological intervention in psychiatry. In Neuro-psychopharmacology. Vol. 4, pp. 249–254. Edited by Bente, D. and Bradley, P. B.. Elsevier: Amsterdam.Google Scholar
Freyhan, F. A. (1961). On classifying psychotropic pharmaca. Comprehensive Psychiatry, 2, 241–247.CrossRefGoogle ScholarPubMed
Gaddum, J. H. (1940). Pharmacology, p. xiii. Oxford University Press: London.Google Scholar
Giurgea, C. (1969). Pharmacological criteria for the classification of tranquilizers. In The Present Status of Psychotropic Drugs, pp. 154–167. Edited by Cerletti, A. and Bové, F. J.. Excerpta Medica: Amsterdam.Google Scholar
Goodman, L. S., and Gilman, A. (1965) (editors). The Pharmacological Basis of Therapeutics, p. 159. 3rd edn.Mac-millan: New York.Google Scholar
Gregg, J. R. (1954). The Language of Taxonomy. Columbia University Press: New York.CrossRefGoogle Scholar
Heimann, H. (1969). Effects of psychotropic drugs on normal man. Confinia Psychiatrica, 12, 205–221.Google ScholarPubMed
Irwin, S. (1959). In Psychopharmacology Frontiers, p. 425. Edited by Kline, N. S.. Little, Brown: Boston.Google Scholar
Irwin, S. (1968). A rational framework for the development, evaluation and use of psychoactive drugs. American Journal of Psychiatry, 124, Suppl., 1–19.CrossRefGoogle ScholarPubMed
Jacobsen, E. (1958). The pharmacological classification of central nervous depressants. Journal of Pharmacy and Pharmacology, 10, 273–294.CrossRefGoogle ScholarPubMed
Jacobsen, E. (1959). The comparative pharmacology of some psychotropic drugs. Bulletin of the World Health Organization, 21, 411–493.Google ScholarPubMed
Jacobsen, E. (1963). The classification of psychotropic drugs. Journal of Neuropsychiatry, 4, 241–246.Google ScholarPubMed
James, W. (1950). The Principles of Psychology. Vol. 2, p. 646. Dover: New York.Google Scholar
Janssen, P. A. J. (1970). Chemical and pharmacological classification of neuroleptics. In The Neuroleptics, pp. 33–44. Edited by Bobon, D. P., Janssen, P. A. J., and Bobon, J.. Karger: Basle.Google ScholarPubMed
Kety, S. S. (1968). Problems in psychiatric nosology from the viewpoint of the biological sciences. In The Role and Methodology of Classification in Psychiatry and Psycho-pathology. Edited by M. M. Katz, J. O. Cole, and W. E. Barton. U.S. Department of Health, Education and Welfare, Public Health Service Publication No. 1584, pp. 190–193.Google Scholar
Klein, D. F. (1968). Diagnosis and pattern of reaction to drug treatment: clinically derived formulations. In The Role and Methodology of Classification in Psychiatry and Psycho-pathology, pp. 466–481. Edited by Katz, M. M., Cole, J. O., and Barton, W. E.. U.S. Department of Health, Education and Welfare: Washington.Google Scholar
Klein, D. F., and Davis, J. M. (1969). Diagnosis and Drug Treatment of Psychiatric Disorders, p. 448. Williams and Wilkins: Baltimore.Google Scholar
Klerman, G. L., and Cole, J. O. (1965). Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacological Reviews, 17, 101–141.Google ScholarPubMed
Kline, N. S. (1969). Nomenclature vs. nature. International Journal of Psychiatry, 7, 292–293.Google ScholarPubMed
Lambert, P. A., and Revol, L. (1969). Classification of neuroleptics. Comprehensive Psychiatry, 10, 50–58.CrossRefGoogle ScholarPubMed
Laurence, D. R. (1966). Clinical Pharmacology, p. 299. Churchill: London.Google Scholar
Leeds, A. A. (1970). A W.H.O. reference center network for information on psychotropic drugs. In The Neuroleptics, pp. 164–167, 2nd edn. Edited by Bobon, D. P., Janssen, P. A. J., and Bobon, J.. Karger: Basle.Google Scholar
Lehmann, H. E. (1956). A dynamic concept of the action of chlorpromazine at physiological and psychological levels. Encéphale, 45, 1113–1118.Google ScholarPubMed
Lehmann, H. E. (1959). Concepts, rationale and research. In Psychopharmacology Frontiers, pp. 21–30. Edited by Kline, N. S.. Little, Brown: Boston.Google Scholar
Lehmann, H. E. (1963). Problems of evaluation and classification in psychopharmacology. In Psychopharmacological Methods, pp. 276–280. Edited by Votava, Z., Horvath, M., and Vinar, O.. State Medical Publishing House: Prague.Google Scholar
Lewin, L. (1931). Phantastica, Narcotic and Stimulating Drugs. Translated from the 2nd German edition by Wirth, P. H. A.. Kegan Paul: London.Google Scholar
Lewis, A. (1952). The classification of schizophrenia. In Psychiatrie Clinique, pp. 247–256. Premier Congrès Mondial de Psychiatrie, Paris, 1950. Hermann: Paris.Google Scholar
Lewis, J. J. (1964). The classification of tranquillizers. The Practitioner, 192, 12–22.Google ScholarPubMed
McClelland, R. M. A., and Mapleson, W. W. (1966). Feature cards. A method of indexing anaesthetic literature. Anaesthesia, 21, 3–18.CrossRefGoogle ScholarPubMed
National Institute of Mental Health, Psychopharmacology service Center Collaborative Study Group (1964). Penothiazine treatment in acute schizophrenia. Archives of General Psychiatry, 10, 246–261.CrossRefGoogle Scholar
Paton, W. D. M., and Payne, J. P. (1968). Pharmacological Principles and Practice. Churchill: London.Google Scholar
Pickford, A. G. A. (1968). An objective method for the generation of an information retrieval language. The Information Scientist, 2, 17–37.Google Scholar
Pickford, A. G. A. (1969). 80-column cards as feature cards. The Information Scientist, 3, 69–79.Google Scholar
Pöldinger, W. (1965). Discussion in Neuro-psychopharmacology, Vol. 4, pp. 267–268. Edited by Bente, D. and Bradley, P. B.. Elsevier: Amsterdam.Google Scholar
Pullon, E. N. (editor) (1970). MIMS Annual Compendium, 1969, p. 8. Haymarket Press: London.Google Scholar
Schild, H. O. (1968). A pharmacological approach to drug receptors. In Importance of Fundamental Principles in Drug Evaluation, p. 257, Proceedings of a symposium, 1968. Edited by Tedeschi, D. H. and Tedeschi, R. E.. Raven Press: New York.Google Scholar
Shepherd, M., Brooke, E. M., Cooper, J. E., and Lin, T.(1968). An experimental approach to psychiatric diagnosis. Acta Psychiatrica Scandinavica, Suppl. 201.Google Scholar
Shepherd, M., Lader, M., and Rodnight, R. (1968). Clinical Psychopharmacology. English Universities Press: London.Google Scholar
Sollmann, T. (1957). A Manual of Pharmacology, p. 43. 8th edn.Saunders: Philadelphia.Google Scholar
Toman, J. E. P. (1962). Neurotropic drugs. In Neurochemistry, pp. 728–765. Edited by Elliott, K. A. C., Page, I. H., and Quastel, J. H.. Thomas: Springfield.Google Scholar
Venables, P. H., and Wing, J. K. (1962). Level of arousal and the subclassification of schizophrenia. Archives of General Psychiatry, 7, 114–119.CrossRefGoogle ScholarPubMed
Vickery, B. C. (1959). Classification and Indexing in Science, p. 12. Butterworths: London.Google Scholar
Virchow, R. (1959). Scientific method and therapeutic standpoints. In Disease, Life, and Man, p. 55. Translated by Rather, L. J.. Stanford University Press: Stanford, Col.Google Scholar
Wilson, A., and Schild, H. O. (1959). Applied Pharmacology (Clark), p. 261. Churchill: London.Google Scholar
World Health Organization (1967). Research in Psycho-pharmacology. Techn. Rep. Ser., 371. World Health Organization: Geneva.Google Scholar
Zubin, J. (1968). In The Role and Methodology of Classification in Psychiatry and Psychopathology, p. 24. Edited by Katz, M. M., Cole, J. O., and Barton, W. E.. U.S. Department of Health, Education, and Welfare: Washington.Google Scholar